These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 32211043)

  • 21. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Cancer Stem Cells: Therapeutic Implications and Challenges.
    Shahoumi LA
    Front Oral Health; 2021; 2():685236. PubMed ID: 35048028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers.
    Lei MML; Lee TKW
    Front Cell Dev Biol; 2021; 9():692940. PubMed ID: 34235155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.
    Chanmee T; Ontong P; Kimata K; Itano N
    Front Oncol; 2015; 5():180. PubMed ID: 26322272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives.
    Méry B; Guy JB; Espenel S; Wozny AS; Simonet S; Vallard A; Alphonse G; Ardail D; Rodriguez-Lafrasse C; Magné N
    World J Stem Cells; 2016 Jan; 8(1):13-21. PubMed ID: 26839637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment.
    Sun HR; Wang S; Yan SC; Zhang Y; Nelson PJ; Jia HL; Qin LX; Dong QZ
    Front Oncol; 2019; 9():1104. PubMed ID: 31709180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects.
    Masoumi J; Jafarzadeh A; Abdolalizadeh J; Khan H; Philippe J; Mirzaei H; Mirzaei HR
    Acta Pharm Sin B; 2021 Jul; 11(7):1721-1739. PubMed ID: 34386318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges.
    Yun EJ; Lo UG; Hsieh JT
    Asian J Urol; 2016 Oct; 3(4):203-210. PubMed ID: 29264188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies.
    Limonta P; Chiaramonte R; Casati L
    Cancers (Basel); 2024 Aug; 16(16):. PubMed ID: 39199632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis.
    Singh D; Khan MA; Siddique HR
    Biochem Pharmacol; 2022 Apr; 198():114955. PubMed ID: 35181312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
    Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
    Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cells as a potential therapeutic target in thyroid carcinoma.
    Vicari L; Colarossi C; Giuffrida D; De Maria R; Memeo L
    Oncol Lett; 2016 Oct; 12(4):2254-2260. PubMed ID: 27698787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy.
    Scioli MG; Storti G; D'Amico F; Gentile P; Fabbri G; Cervelli V; Orlandi A
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cells and tumorigenesis.
    Zhu P; Fan Z
    Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties.
    Mahmoodi S; Nezafat N; Negahdaripour M; Ghasemi Y
    Curr Mol Med; 2019; 19(1):2-11. PubMed ID: 30714514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer.
    Connor EV; Saygin C; Braley C; Wiechert AC; Karunanithi S; Crean-Tate K; Abdul-Karim FW; Michener CM; Rose PG; Lathia JD; Reizes O
    J Ovarian Res; 2019 Nov; 12(1):112. PubMed ID: 31735168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
    Saeg F; Anbalagan M
    Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Mathematical Model of Average Dynamics in a Stem Cell Hierarchy Suggests the Combinatorial Targeting of Cancer Stem Cells and Progenitor Cells as a Potential Strategy against Tumor Growth.
    Molina-Peña R; Tudon-Martinez JC; Aquines-Gutiérrez O
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32932755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.